Silverfin false false 31/10/2024 01/11/2023 31/10/2024 E Birgiolaite 15 July 2025 no description of principal activity 14443043 2024-10-31 14443043 core:CurrentFinancialInstruments 2024-10-31 14443043 core:CurrentFinancialInstruments 2023-10-31 14443043 2023-10-31 14443043 core:ShareCapital 2024-10-31 14443043 core:ShareCapital 2023-10-31 14443043 core:RetainedEarningsAccumulatedLosses 2024-10-31 14443043 core:RetainedEarningsAccumulatedLosses 2023-10-31 14443043 2023-11-01 2024-10-31 14443043 bus:FilletedAccounts 2023-11-01 2024-10-31 14443043 bus:SmallEntities 2023-11-01 2024-10-31 14443043 bus:AuditExemptWithAccountantsReport 2023-11-01 2024-10-31 14443043 bus:PrivateLimitedCompanyLtd 2023-11-01 2024-10-31 14443043 bus:Director1 2023-11-01 2024-10-31 14443043 2022-11-01 2023-10-31 14443043 core:CurrentFinancialInstruments 2023-11-01 2024-10-31 iso4217:GBP xbrli:pure

Company No: 14443043 (England and Wales)

EB SURGICAL LIMITED

Unaudited Financial Statements
For the financial year ended 31 October 2024
Pages for filing with the registrar

EB SURGICAL LIMITED

Unaudited Financial Statements

For the financial year ended 31 October 2024

Contents

EB SURGICAL LIMITED

STATEMENT OF FINANCIAL POSITION

As at 31 October 2024
EB SURGICAL LIMITED

STATEMENT OF FINANCIAL POSITION (continued)

As at 31 October 2024
Note 31.10.2024 31.10.2023
£ £
Current assets
Debtors 3 417 397
Cash at bank and in hand 6,437 6,508
6,854 6,905
Creditors: amounts falling due within one year 4 ( 6,123) ( 6,821)
Net current assets 731 84
Total assets less current liabilities 731 84
Net assets 731 84
Capital and reserves
Called-up share capital 100 100
Profit and loss account 631 ( 16 )
Total shareholder's funds 731 84

For the financial year ending 31 October 2024 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The financial statements of EB Surgical Limited (registered number: 14443043) were approved and authorised for issue by the Director. They were signed on its behalf by:

E Birgiolaite
Director

15 July 2025

EB SURGICAL LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 October 2024
EB SURGICAL LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 October 2024
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial period, unless otherwise stated.

General information and basis of accounting

EB Surgical Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is International House, 36-38 Cornhill, London, EC3V 3NG, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The director has assessed the Statement of Financial Position and likely future cash flows at the date of approving these financial statements. The director has a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Reporting period length

The company's previous financial statements were prepared from incorporation on 25 October 2022 to 31 October 2023. The financial statements are therefore not entirely comparable.

Turnover

Turnover is stated net of VAT and trade discounts and is recognised when the significant risks and rewards are considered to have been transferred to the buyer. Turnover from the supply of services represents the value of services provided under contracts to the extent that there is a right to consideration and is recorded at the fair value of the consideration received or receivable. Where a contract has only been partially completed at the Statement of Financial Position date turnover represents the fair value of the service provided to date based on the stage of completion of the contract activity at the Statement of Financial Position date. Where payments are received from customers in advance of services provided, the amounts are recorded as deferred income and included as part of creditors due within one year.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Statement of Financial Position date.

Trade and other debtors

Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts, except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Trade and other creditors

Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.

2. Employees

31.10.2024 31.10.2023
Number Number
Monthly average number of persons employed by the Company during the year, including the director 1 1

3. Debtors

31.10.2024 31.10.2023
£ £
Prepayments 417 397

4. Creditors: amounts falling due within one year

31.10.2024 31.10.2023
£ £
Amounts owed to director 960 502
Accruals 2,196 2,100
Corporation tax 2,967 4,219
6,123 6,821

There are no amounts included above in respect of which any security has been given by the company.